GSK to acquire vaccine technology company Okairos
UK-based pharmaceutical major GlaxoSmithKline (GSK) has purchased Switzerland-based vaccine company Okairos in a deal worth €250m.
By
Liam Stoker
Latest articles
All Articles
Sanofi multiple sclerosis treatment wins US approval
Sanofi has won US Food and Drug Administration approval for its multiple sclerosis medication Aubagio.
BySanofi dengue fever vaccine shows potential
A vaccine for dengue fever developed by Sanofi has shown the potential to protect against three of the four…
ByIndian Supreme Court begins final hearing on Glivec patent case
Novartis has taken to the stand in India's Supreme Court, arguing for patent protection for its cancer drug Glivec…
ByUK health bodies alerted after latest anthrax death
The UK Department of Health has issued a warning to the nation's National Health Service (NHS) following the death…
ByAstraZeneca pulls obesity drug after allergic reaction
AstraZeneca has decided to discontinue the development of obesity drug AZD2820 after a patient given the drug as part…
ByJazz Pharma spins off women’s health business for $95m
US-based pharmaceutical company Jazz Pharmaceuticals has announced a deal to sell its women's health business to Meda for $95m…
ByDrug advisory panel backs Novartis cystic fibrosis drug
A drug advisory panel has recommended that the US Food and Drug Administration approve Novartis' inhaled cystic fibrosis medication…
ByPfizer leukaemia drug receives US approval
The US Food and Drug Administration has approved Pfizer’s Bosulif, used to treat a rare type of leukaemia usually…
By